Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
2018 · Oncogene · 137 citations
https://doi.org/10.1038/s41388-018-0347-4
J
Jiehai Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
533
Citations
10
h-index
10
i10-index
Jiehai Yu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Genetic factors in colorectal cancer & Colorectal and Anal Carcinomas & Colorectal Cancer Surgical Treatments. The author has an h-index of 10, co-authored 26 publications.
ORCID: 0000-0001-7554-0018Papers by this author
worksLong-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study
2024 · BMC Cancer · 6 citations
https://doi.org/10.1186/s12885-024-11836-3
The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study
2024 · BMC Cancer · 6 citations
https://doi.org/10.1186/s12885-024-11821-w
Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study
2025 · npj Precision Oncology · 6 citations
https://doi.org/10.1038/s41698-025-01018-0
Proposal of a novel model for identifying complete response and nonoperative management in dMMR colon cancer following neoadjuvant immunotherapy: a retrospective cohort study
2025 · International Journal of Surgery · 0 citations
https://doi.org/10.1097/js9.0000000000003602
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat